Antimicrobial stewardship in pediatric care: Strategies and future directions

Jason G. Newland; Ritu Banerjee; Jeffrey S. Gerber; Adam L. Hersh; Leah Steinke; Scott J. Weissman

doi:10.1002/j.1875-9114.2012.01155.x

Antimicrobial stewardship in pediatric care: Strategies and future directions

Jason G. Newland, Ritu Banerjee, Jeffrey S. Gerber, Adam L. Hersh, Leah Steinke, Scott J. Weissman

Research output: Contribution to journal › Review article › peer-review

22 Scopus citations

Abstract

Antimicrobial stewardship programs (ASPs) are an effective strategy for improving the quality and safety of antimicrobial prescribing for hospitalized patients. Pediatric ASPs are in their early stages of development, and there are unique issues relevant to children. The imperative to ensure that antimicrobials are prescribed judiciously is highlighted by the ongoing epidemic increase in antimicrobial-resistant infections and the simultaneous decline in the rate of new drug development. In this review we describe the process of ASP development for pediatrics, review existing data regarding the impact of pediatric ASPs, and describe the priorities and challenges for ASP research including study design and appropriate end points.

Original language	English
Pages (from-to)	735-743
Number of pages	9
Journal	Pharmacotherapy
Volume	32
Issue number	8
DOIs	https://doi.org/10.1002/j.1875-9114.2012.01155.x
State	Published - Aug 2012

Keywords

Antibiograms
Antimicrobial stewardship
Pediatrics
Prior authorization
Prospective audit with feedback
Special populations

Access to Document

10.1002/j.1875-9114.2012.01155.x

Cite this

@article{9131cf489b35488389f03cc472222180,

title = "Antimicrobial stewardship in pediatric care: Strategies and future directions",

abstract = "Antimicrobial stewardship programs (ASPs) are an effective strategy for improving the quality and safety of antimicrobial prescribing for hospitalized patients. Pediatric ASPs are in their early stages of development, and there are unique issues relevant to children. The imperative to ensure that antimicrobials are prescribed judiciously is highlighted by the ongoing epidemic increase in antimicrobial-resistant infections and the simultaneous decline in the rate of new drug development. In this review we describe the process of ASP development for pediatrics, review existing data regarding the impact of pediatric ASPs, and describe the priorities and challenges for ASP research including study design and appropriate end points.",

keywords = "Antibiograms, Antimicrobial stewardship, Pediatrics, Prior authorization, Prospective audit with feedback, Special populations",

author = "Newland, {Jason G.} and Ritu Banerjee and Gerber, {Jeffrey S.} and Hersh, {Adam L.} and Leah Steinke and Weissman, {Scott J.}",

year = "2012",

month = aug,

doi = "10.1002/j.1875-9114.2012.01155.x",

language = "English",

volume = "32",

pages = "735--743",

journal = "Pharmacotherapy",

issn = "0277-0008",

number = "8",

}

TY - JOUR

T1 - Antimicrobial stewardship in pediatric care

T2 - Strategies and future directions

AU - Newland, Jason G.

AU - Banerjee, Ritu

AU - Gerber, Jeffrey S.

AU - Hersh, Adam L.

AU - Steinke, Leah

AU - Weissman, Scott J.

PY - 2012/8

Y1 - 2012/8

N2 - Antimicrobial stewardship programs (ASPs) are an effective strategy for improving the quality and safety of antimicrobial prescribing for hospitalized patients. Pediatric ASPs are in their early stages of development, and there are unique issues relevant to children. The imperative to ensure that antimicrobials are prescribed judiciously is highlighted by the ongoing epidemic increase in antimicrobial-resistant infections and the simultaneous decline in the rate of new drug development. In this review we describe the process of ASP development for pediatrics, review existing data regarding the impact of pediatric ASPs, and describe the priorities and challenges for ASP research including study design and appropriate end points.

AB - Antimicrobial stewardship programs (ASPs) are an effective strategy for improving the quality and safety of antimicrobial prescribing for hospitalized patients. Pediatric ASPs are in their early stages of development, and there are unique issues relevant to children. The imperative to ensure that antimicrobials are prescribed judiciously is highlighted by the ongoing epidemic increase in antimicrobial-resistant infections and the simultaneous decline in the rate of new drug development. In this review we describe the process of ASP development for pediatrics, review existing data regarding the impact of pediatric ASPs, and describe the priorities and challenges for ASP research including study design and appropriate end points.

KW - Antibiograms

KW - Antimicrobial stewardship

KW - Pediatrics

KW - Prior authorization

KW - Prospective audit with feedback

KW - Special populations

UR - http://www.scopus.com/inward/record.url?scp=84864629098&partnerID=8YFLogxK

U2 - 10.1002/j.1875-9114.2012.01155.x

DO - 10.1002/j.1875-9114.2012.01155.x

M3 - Review article

C2 - 23307521

AN - SCOPUS:84864629098

SN - 0277-0008

VL - 32

SP - 735

EP - 743

JO - Pharmacotherapy

JF - Pharmacotherapy

IS - 8

ER -

Antimicrobial stewardship in pediatric care: Strategies and future directions

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this